Results 1 to 10 of about 619,827 (286)

Nonneuroendocrine Neoplasms of the Pituitary Region [PDF]

open access: yesJournal of Clinical Endocrinology and Metabolism, 2019
Although most sellar lesions are related to pituitary adenomas, the region gives rise to a variety of neoplasms that can be associated with substantial morbidity and/or mortality.Information from reviews and guidelines of relevant societies dealing with such neoplasms, as well as articles that have provided new developments that made important ...
Gregory Kaltsas   +2 more
exaly   +5 more sources

A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis [PDF]

open access: yesLancet Diabetes and Endocrinology,the
No comprehensive classification system that guides prognosis and therapy of pituitary adenomas exists. The 2022 WHO histopathology-based classification system can only be applied to lesions that are resected, which represent few clinically significant ...
John Wass
exaly   +3 more sources

Analyses and treatments of postoperative nasal complications after endonasal transsphenoidal resection of pituitary neoplasms. [PDF]

open access: yesMedicine (Baltimore), 2017
In this study, we analyze and discuss the treatments of postoperative nasal complications after endonasal transsphenoidal resection of pituitary neoplasms (PNs).
Cheng Y   +8 more
europepmc   +2 more sources

Treatment of pituitary neoplasms with temozolomide [PDF]

open access: yesCancer, 2010
AbstractTemozolomide, an orally administered alkylating agent, is used to treat malignant gliomas. Recent reports also have documented its efficacy in the treatment of pituitary adenomas and carcinomas. Temozolomide methylates DNA and thereby exhibits an antitumor effect.
Luis V, Syro   +9 more
openaire   +3 more sources

Infiltrating pituitary neoplasms in the rat [PDF]

open access: yesLaboratory Animals, 1979
Summary 11 cases of spontaneous pituitary neoplasms in rats, which showed infiltration into brain tissue, are reported. This represents an incidence of about 0·42%.
G, Magnusson, S K, Majeed, C, Gopinath
openaire   +3 more sources

Intravenous Thrombolysis for Ischemic Stroke Patients with Pituitary Neoplasms: A Nationwide Study and Scoping Review [PDF]

open access: yesNeuroSci
Objective: The safety of intravenous thrombolysis (IVT) for acute ischemic stroke (AIS) patients with pituitary neoplasms is unclear. This study aims to assess IVT’s safety and efficacy in this patient population.
Matthew K. McIntyre   +5 more
doaj   +2 more sources

Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time? [PDF]

open access: yesJournal of the Endocrine Society, 2021
Abstract The WHO Classification of Endocrine Tumours designates pituitary neoplasms as adenomas. A proposed nomenclature change to pituitary neuroendocrine tumors (PitNETs) has been met with concern by some stakeholder groups. The Pituitary Society coordinated the Pituitary Neoplasm Nomenclature (PANOMEN) workshop to address the topic ...
Ken Ho   +47 more
openaire   +10 more sources

The hidden hedgehog of the pituitary: hedgehog signaling in development, adulthood and disease of the hypothalamic-pituitary axis

open access: yesFrontiers in Endocrinology, 2023
Hedgehog signaling plays pivotal roles in embryonic development, adult homeostasis and tumorigenesis. However, its engagement in the pituitary gland has been long underestimated although Hedgehog signaling and pituitary embryogenic development are ...
Yehan Bian, Heidi Hahn, Anja Uhmann
doaj   +2 more sources

Clinical Biology of the Pituitary Adenoma

open access: yesEndocrine Reviews, 2022
All endocrine glands are susceptible to neoplastic growth, yet the health consequences of these neoplasms differ between endocrine tissues. Pituitary neoplasms are highly prevalent and overwhelmingly benign, exhibiting a spectrum of diverse behaviors and
Shlomo Melmed   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy